Hit podcast host Joe Rogan has tested positive for COVID-19, and the media is reporting he’s taking a “horse dewormer” to treat the infection.
Rogan announced via Instagram earlier this week he had been diagnosed with the coronavirus, adding he began taking monoclonal antibodies, ivermectin, azithromycin, prednisone, as well as an “NAD drip” and a “vitamin drip,” which he took for “three days in a row.”
It seems, however, the media — namely, CNN — has focused only one of the drugs the juggernaut took to treat his COVID-19 infection.
The network shows hosted by Erin Burnett and Don Lemon each featured chyrons stating Rogan took a “livestock drug” and a “horse dewormer.”
While it is accurate the drug ivermectin is approved by the Food and Drug Administration to treat parasitic infections in animals, it is also true it has been authorized by the federal agency to treat similar issues in humans.
The FDA has, however, discouraged people from taking ivermectin to treat COVID-19 infections and the Mississippi state epidemiologist, Dr. Paul Byers, said last week at least 70% of the calls to the Poison Control Center have been due to adverse ivermectin reactions. There is some evidence, though, to suggest the a five-day course of the drug could reduce the length of the virus’ symptoms.
“A 5-day course of ivermectin was found to be safe and effective in treating adult patients with mild COVID-19,” explained the authors of a December study of 72 hospitalized patients in Dhaka, Bangladesh. “Larger trials will be needed to confirm these preliminary findings.”
Researchers in the U.K. are also investigating ivermectin to treat COVID-19.
And in a Nobel lecture from 2015, Satoshi Ōmura described the drug as “improving the overall health and welfare of hundreds of millions of men, women, and children, mostly in poor and impoverished communities,” adding its impact “remains unmatched.”
***As the number of voices facing big-tech censorship continues to grow, please sign up for Faithwire’s daily newsletter and download the CBN News app, developed by our parent company, to stay up-to-date with the latest news from a distinctly Christian perspective.***